X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs SUN PHARMA - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD SUN PHARMA LUPIN LTD/
SUN PHARMA
 
P/E (TTM) x 17.7 16.8 105.5% View Chart
P/BV x 4.1 3.4 121.9% View Chart
Dividend Yield % 0.7 0.7 109.9%  

Financials

 LUPIN LTD   SUN PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
SUN PHARMA
Mar-17
LUPIN LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,127842 252.6%   
Low Rs1,294572 226.1%   
Sales per share (Unadj.) Rs304.1131.6 231.0%  
Earnings per share (Unadj.) Rs50.432.7 154.1%  
Cash flow per share (Unadj.) Rs60.738.0 159.8%  
Dividends per share (Unadj.) Rs7.503.50 214.3%  
Dividend yield (eoy) %0.40.5 88.6%  
Book value per share (Unadj.) Rs243.8152.7 159.6%  
Shares outstanding (eoy) m450.582,399.26 18.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.65.4 104.7%   
Avg P/E ratio x33.921.6 156.9%  
P/CF ratio (eoy) x28.218.6 151.4%  
Price / Book Value ratio x7.04.6 151.5%  
Dividend payout %14.910.7 139.1%   
Avg Mkt Cap Rs m770,7401,696,877 45.4%   
No. of employees `00016.417.5 93.3%   
Total wages/salary Rs m21,07749,023 43.0%   
Avg. sales/employee Rs Th8,379.618,028.3 46.5%   
Avg. wages/employee Rs Th1,289.02,798.8 46.1%   
Avg. net profit/employee Rs Th1,388.74,479.5 31.0%   
INCOME DATA
Net Sales Rs m137,016315,784 43.4%  
Other income Rs m1,8776,232 30.1%   
Total revenues Rs m138,893322,016 43.1%   
Gross profit Rs m37,535100,893 37.2%  
Depreciation Rs m4,63512,648 36.6%   
Interest Rs m4463,998 11.2%   
Profit before tax Rs m34,33090,479 37.9%   
Minority Interest Rs m-880-   
Prior Period Items Rs m099 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,53612,116 95.2%   
Profit after tax Rs m22,70778,462 28.9%  
Gross profit margin %27.431.9 85.7%  
Effective tax rate %33.613.4 250.9%   
Net profit margin %16.624.8 66.7%  
BALANCE SHEET DATA
Current assets Rs m97,790329,537 29.7%   
Current liabilities Rs m53,872178,870 30.1%   
Net working cap to sales %32.147.7 67.2%  
Current ratio x1.81.8 98.5%  
Inventory Days Days8579 107.2%  
Debtors Days Days12183 145.6%  
Net fixed assets Rs m86,379204,766 42.2%   
Share capital Rs m9012,399 37.6%   
"Free" reserves Rs m105,735363,997 29.0%   
Net worth Rs m109,844366,397 30.0%   
Long term debt Rs m53,73914,361 374.2%   
Total assets Rs m224,378614,102 36.5%  
Interest coverage x77.923.6 329.8%   
Debt to equity ratio x0.50 1,248.2%  
Sales to assets ratio x0.60.5 118.8%   
Return on assets %10.313.4 76.8%  
Return on equity %20.721.4 96.5%  
Return on capital %21.224.8 85.4%  
Exports to sales %49.10-   
Imports to sales %7.40-   
Exports (fob) Rs m67,244NA-   
Imports (cif) Rs m10,199NA-   
Fx inflow Rs m71,40544,118 161.8%   
Fx outflow Rs m17,80724,484 72.7%   
Net fx Rs m53,59819,634 273.0%   
CASH FLOW
From Operations Rs m-3,69070,822 -5.2%  
From Investments Rs m-69,434-42,216 164.5%  
From Financial Activity Rs m58,126-22,854 -254.3%  
Net Cashflow Rs m-14,9986,107 -245.6%  

Share Holding

Indian Promoters % 46.6 63.7 73.2%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 5.1 220.3%  
FIIs % 31.9 23.0 138.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 8.3 121.7%  
Shareholders   98,259 133,026 73.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   FULFORD INDIA  SUVEN LIFE  STERLING BIOTECH  WOCKHARDT LTD.  VENUS REMEDIES  

Compare LUPIN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Tata Stocks Rally(Closing)

Indian share markets continued to trade range bound in afternoon session with market participants awaiting the US Federal Reserve's policy statement this week.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

Kim Jong Un Is Keeping Traders Busy(Daily Profit Hunter)

Sep 6, 2017

You shouldn't worry about North Kore, War or Market Corrections.

180,000%: The Returns That Could Have Been(The 5 Minute Wrapup)

Sep 7, 2017

For successful investing in small caps, it's important to know when not to press the panic button.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

Home Prices Chart a Steady Rise(Chart Of The Day)

Sep 7, 2017

Home prices data throws up a positive surprise.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Sep 19, 2017 03:36 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - FULFORD INDIA COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS